Candesartan.
Armstrong
Paul W
PW
Lorell
Beverly H
BH
Nissen
Steven
S
Borer
Jeffrey
J
D026683:Advisory Committees; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D004348:Drug Labeling; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D044140:Receptor, Angiotensin, Type 1; D013777:Tetrazoles / Q000627:therapeutic use*
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D044140:Receptor, Angiotensin, Type 1; D013777:Tetrazoles; C081643:candesartan